IMNM · Forms 3, 4, 5

Insider trades at Immunome Inc.

3 insiders sold $5.7M of Immunome Inc. stock on the open market in the last 90 days.

Every Form 3, 4 and 5 filed for Immunome Inc. (IMNM) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Jack HigginsChief Scientific OfficerOption exercise18,000$1.35$24KForm 4
Jack HigginsChief Scientific OfficerSell (10b5-1 plan)13,200$25.32$334KForm 4
Jack HigginsChief Scientific OfficerGift8,800Form 4
Isaac BarchasDirectorSell (10b5-1 plan)11,048$27.25$301KForm 4
Isaac BarchasDirectorSell (10b5-1 plan)62,291$26.23$1.6MForm 4
Isaac BarchasDirectorSell (10b5-1 plan)10,125$26.07$264KForm 4
Isaac BarchasDirectorSell (10b5-1 plan)15,248$26.06$397KForm 4
Isaac BarchasDirectorSell (10b5-1 plan)20,840$26.06$543KForm 4
Kinney HornCHIEF BUSINESS OFFICEROption exercise50,366$12.92$651KForm 4
Kinney HornCHIEF BUSINESS OFFICEROption exercise40,250$10.60$427KForm 4
Kinney HornCHIEF BUSINESS OFFICERSell (10b5-1 plan)90,616$25.09$2.3MForm 4
Kinney HornCHIEF BUSINESS OFFICERAward31,250Form 4
Philip TsaiChief Technical OfficerAward38,250Form 4
Sandra G. StonemanCHIEF LEGAL OFFICER & GCAward38,250Form 4
Jack HigginsChief Scientific OfficerAward38,250Form 4
Max RosettChief Financial OfficerAward47,250Form 4
Robert LechleiderChief Medical OfficerAward54,000Form 4
Clay B SiegallPresident and CEOAward180,000Form 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.